These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Promotion, prediction, and prevention of progression in diabetic nephropathy. Rossing P Dan Med Bull; 1998 Sep; 45(4):354-69. PubMed ID: 9777288 [No Abstract] [Full Text] [Related]
26. Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits. Winiarska K; Szymanski K; Gorniak P; Dudziak M; Bryla J Biochimie; 2009 Feb; 91(2):261-70. PubMed ID: 18957317 [TBL] [Abstract][Full Text] [Related]
31. Pathogenesis of diabetic nephropathy: experimental approaches. The Second Hyonam Kidney Laboratory International Symposium. Seoul, Korea, January 21, 1995. Proceedings. Kidney Int Suppl; 1995 Sep; 51():S1-65. PubMed ID: 7474680 [No Abstract] [Full Text] [Related]
32. [Diabetic nephropathy: the role of blood pressure and extra-cellular volume in its pathogenesis and treatment]. Luik PT; Visser FW; Dullaart RP; Navis GJ Ned Tijdschr Geneeskd; 2004 Apr; 148(17):855-6; author reply 856. PubMed ID: 15141656 [No Abstract] [Full Text] [Related]
33. Pravastatin modulates early diabetic nephropathy in an experimental model of diabetic renal disease. Casey RG; Joyce M; Roche-Nagle G; Chen G; Bouchier-Hayes D J Surg Res; 2005 Feb; 123(2):176-81. PubMed ID: 15680375 [TBL] [Abstract][Full Text] [Related]
34. The relationship between glomerular structure and function in insulin-dependent diabetes. Bilous RW Nephrologie; 1989; 10(4):195-200. PubMed ID: 2699009 [TBL] [Abstract][Full Text] [Related]
35. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy. Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828 [TBL] [Abstract][Full Text] [Related]
36. Protective effect of polyphenol-containing azuki bean (Vigna angularis) seed coats on the renal cortex in streptozotocin-induced diabetic rats. Sato S; Yamate J; Hori Y; Hatai A; Nozawa M; Sagai M J Nutr Biochem; 2005 Sep; 16(9):547-53. PubMed ID: 16115543 [TBL] [Abstract][Full Text] [Related]
37. [Pathogenesis of diabetic nephropathy: the role of inflammation]. Ogawa D; Makino H Nihon Rinsho; 2012 Jul; 70 Suppl 5():389-92. PubMed ID: 23156425 [No Abstract] [Full Text] [Related]
38. [History of nephrology in the last 100 years: Diabetic nephropathies]. Kikkawa R Nihon Naika Gakkai Zasshi; 2002 May; 91(5):1489-91. PubMed ID: 12082740 [No Abstract] [Full Text] [Related]
39. [Considerations on the histogenesis and anatomoclinical correlations in diabetic glomerulosclerosis]. Tudose N; Georgescu L Rev Med Chir Soc Med Nat Iasi; 1969; 73(1):145-52. PubMed ID: 5799856 [No Abstract] [Full Text] [Related]
40. Toxic effects of high doses of protamine sulphate, with special reference to the kidneys. PAVONE M Panminerva Med; 1962 Jan; 4():4-8. PubMed ID: 14484649 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]